Why Rare Cannabinoids Are In Demand with WTR's Jesse Redmond and BayMedica's Jerry Griffin

from WTR Small-Cap Spotlight · host Water Tower Research

Send us Fan MailBayMedica is the commercial business arm of rare cannabinoids-based drug developer InMed Pharmaceuticals (NASDAQ: INM). BayMedica produces and sells synthesized high purity and consistent rare cannabinoid ingredients to the Health & Wellness sector. BayMedica’s business has quickly grown its annual revenues to more than $5 million over the last 12 months.

Episode metadata supplied by the publisher feed · Published Feb 28, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Why Rare Cannabinoids Are In Demand with WTR's Jesse Redmond and BayMedica's Jerry Griffin

0:00 39:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Thinking Cap Solutions Podcast Mickey Maher & Corey Kay 🎙 Thinking Cap Solutions Podcast – Unlock the power of content, audience engagement, and leadership.With 30+ years in media, content strategy, and senior leadership, Mickey & Corey share real-world lessons, insights, and strategies to help brands, businesses, and leaders grow.🚀 From podcasting and content creation to audience engagement and leadership coaching, we break down what works, what doesn’t, and how to cut through the noise.🎧 Listen, learn, and lead with impact.

Frequently Asked Questions

How long is this episode of WTR Small-Cap Spotlight?

This episode is 39 minutes long.

When was this WTR Small-Cap Spotlight episode published?

This episode was published on February 28, 2024.

Can I download this WTR Small-Cap Spotlight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!